Discover 161 paid clinical trials in Honolulu, Hawaii. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 161
Featured
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
for
Obesity or Overweight
Location: Honolulu HI, Walnut Creek CA, Irvine CA, Portland OR,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07351045
Phase3, Recruiting
Featured
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
for
Parkinson's Disease
Location: Honolulu HI, San Francisco CA, Stanford CA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 50 - 70+
Code: NCT07174310
Phase3, Recruiting
Featured
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
for
Alzheimers Disease
Location: Honolulu HI, Oakland CA, Sherman Oaks CA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 50 - 70+
Code: NCT07177352
Phase3, Recruiting
Featured
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
for
Non Small Cell Lung Cancer
Location: Honolulu HI, Huntington Beach CA, Lancaster CA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT04928846
Phase3, Recruiting
Featured
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
for
Non-Small Cell Lung Cancer
Location: Honolulu HI, Oxnard CA, Los Angeles CA, Reno NV,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06568939
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
for
Advanced Esophageal Adenocarcinoma,
Location: Honolulu HI, ‘Aiea HI, ‘Ewa Beach HI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06203600
Phase2, Phase3, Recruiting
Active & Responsive
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
for
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Location: Honolulu HI, ‘Aiea HI, ‘Ewa Beach HI, Santa Rosa CA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT07018869
Phase3, Recruiting
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
for
Diabetes Mellitus, Type 2, Hypertension,
Location: Honolulu HI, Santa Rosa CA, Concord CA, Canoga Park CA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07064473
Phase3, Recruiting
Active & Responsive
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
for
Obesity, Overweight
Location: Honolulu HI, Walnut Creek CA, Long Beach CA,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07684235
Phase3, Recruiting
Active & ResponsiveNew
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
for
Overweight, Obesity
Location: Honolulu HI, Indianapolis IN, Lexington KY, Conyers GA,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07745504
Phase3, Recruiting
Active & ResponsiveNew
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
for
Overweight, Obesity
Location: Honolulu HI, Corvallis OR, Huntington Park CA,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07770841
Phase3, Recruiting
Active & Responsive
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
for
Obesity, Overweight
Location: Honolulu HI, Sacramento CA, Rolling Hills Estates CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07321886
Phase3, Recruiting
Active & Responsive
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
for
Chronic Migraine
Location: Honolulu HI, Thousand Oaks CA, Los Angeles CA,
Sponsor: Merz Therapeutics GmbH
Sex: All
Age: 18+
Code: NCT07018713
Phase3, Recruiting
Active & Responsive
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
for
Episodic Migraine
Location: Honolulu HI, Thousand Oaks CA, Torrance CA,
Sponsor: Merz Therapeutics GmbH
Sex: All
Age: 18+
Code: NCT07018700
Phase3, Recruiting
Active & Responsive
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients
for
Epilepsy, Healthy Volunteer
Location: Honolulu HI, Tucson AZ, Cypress TX, Farmington Hills MI,
Sponsor: Suninflam Inc
Sex: All
Age: 18 - 70
Code: NCT07051629
Phase1, Recruiting
Active & Responsive
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
Location: Honolulu HI, San Francisco CA, Rancho Mirage CA,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06538064
Recruiting
Active & Responsive
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
for
Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos
Location: Honolulu HI, Santa Rosa CA, Napa CA, San Luis Obispo CA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT07091617
Recruiting
Active & Responsive
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
for
Acute Myeloid Leukemia
Location: Honolulu HI, San Francisco CA, Long Beach CA, Orange CA,
Sponsor: PedAL BCU, LLC
Sex: All
Age: 0 - 21
Code: NCT05183035
Phase3, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer